Promoter Methylation of TRIM9 as a Marker for Detection of Circulating Tumor DNA in Breast Cancer Patients

SpringerPlus - Germany
doi 10.1186/s40064-015-1423-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA

Journal of Clinical Medicine
2018English

Circulating Tumor Cells Detection in Tumor Draining Vein of Breast Cancer Patients

Scientific Reports
Multidisciplinary
2019English

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

Clinical Cancer Research
Cancer ResearchOncology
2019English

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer

Genes
Genetics
2016English

Circulating Cell-Free DNA and Its Integrity as a Prognostic Marker for Breast Cancer

SpringerPlus
Multidisciplinary
2015English

Circulating Tumor DNA Detection in Lung Cancer Patients Before and After Surgery

Scientific Reports
Multidisciplinary
2016English

Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study

Clinical Genitourinary Cancer
OncologyUrology
2016English

Progesterone Receptor Isoform-Specific Promoter Methylation: Association of PRA Promoter Methylation With Worse Outcome in Breast Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2011English

Serum CA19-9 as a Marker of Circulating Tumor Cells in First Reflux Blood of Colorectal Cancer Patients

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy